Search

Author/Creator Hoff, Daniel

1. A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. Issue 1 (December 2017)

Authors:
Laquente, Berta; Lopez-Martin, Jose; Richards, Donald; Illerhaus, Gerald; Chang, David; Kim, George; Stella, Philip; Richel, Dirk; Szcylik, Cezary; Cascinu, Stefano; Frassineti, G.; Ciuleanu, Tudor; Hurt, Karla; Hynes, Scott; Lin, Ji; Lin, Aimee; Hoff, Daniel; Calvo, Emiliano
Journal:
BMC cancer
Issue:
Volume 17:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin. Issue 1 (December 2016)

Authors:
Hall, Jason; Marlow, Laura; Mathias, Adam; Dawson, Louis; Durham, William; Meshaw, Kenneth; Mullin, Robert; Synnott, Aidan; Small, Daniel; Krishna, Murli; Hoff, Daniel; Schüler, Julia; Hart, Steven; Couch, Fergus; Colon-Otero, Gerardo; Copland, John
Journal:
Journal of translational medicine
Issue:
Volume 14:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search